Published in Biopolymers on May 01, 1991
Novel protocol for the chemical synthesis of crustacean hyperglycemic hormone analogues--an efficient experimental tool for studying their functions. PLoS One (2012) 0.79
Frog skin opioid peptides: a case for environmental mimicry. Environ Health Perspect (1994) 0.77
Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol (2000) 1.97
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol (2008) 1.46
Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol Today (1996) 1.45
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol (2007) 1.45
A new selective antagonist of the nociceptin receptor. Br J Pharmacol (1998) 1.41
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem (1997) 1.36
Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol Med (1995) 1.34
Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med (2000) 1.24
Topology of the calmodulin-melittin complex. J Mol Biol (1998) 1.22
A bioactive fullerene peptide. J Med Chem (1994) 1.21
Brain auditory activation measured by near-infrared spectroscopy (NIRS) in neonates. Pediatr Res (2001) 1.18
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol (2000) 1.18
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. Br J Anaesth (2009) 1.15
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. J Med Chem (1999) 1.11
Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. Proc Natl Acad Sci U S A (2000) 1.11
High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int (1995) 1.09
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.08
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol (1998) 1.07
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity. J Med Chem (1997) 1.05
Solution structure of human calcitonin in membrane-mimetic environment: the role of the amphipathic helix. Proteins (1998) 1.03
Probing the surface of a sweet protein: NMR study of MNEI with a paramagnetic probe. Protein Sci (2001) 1.02
Function of negative charge in the "address domain" of deltorphins. J Med Chem (1991) 1.02
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem (1998) 1.02
Nociceptin/orphanin FQ receptor ligands. Peptides (2000) 1.02
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur J Pharmacol (1996) 1.00
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. J Med Chem (2000) 1.00
Effect of the three-dimensional structure on the deamidation reaction of ribonuclease A. J Pept Res (1999) 0.98
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. J Leukoc Biol (1996) 0.96
Structural determination of the active site of a sweet protein. A 1H NMR investigation of pMNEI. FEBS Lett (1992) 0.96
NMR studies of protein surface accessibility. J Biol Chem (2001) 0.95
Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med (2001) 0.95
Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity. Peptides (1993) 0.95
Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.94
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents. Mini Rev Med Chem (2009) 0.94
Solution structure of a sweet protein: NMR study of MNEI, a single chain monellin. J Mol Biol (2001) 0.94
Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer. Br J Pharmacol (2010) 0.94
Selective opioid dipeptides. Biochem Biophys Res Commun (1994) 0.94
Conformational preferences of [Leu5]enkephalin in biomimetic media. Investigation by 1H NMR. Eur J Biochem (1990) 0.92
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci (2003) 0.92
What peptides these deltorphins be. Prog Neurobiol (1999) 0.91
Experimental pancreatic cancer in the rat treated by photodynamic therapy. Br J Surg (1994) 0.91
Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus. Scand J Rheumatol (2010) 0.91
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance. Br J Pharmacol (2007) 0.91
Total body water estimation using bioelectrical impedance: a meta-analysis of the data available in the literature. Acta Diabetol (2003) 0.89
Derivatives as 5HT1A receptor ligands--past and present. Curr Med Chem (2005) 0.89
Pharmacological dissection of vascular effects caused by activation of protease-activated receptors 1 and 2 in anesthetized rats. FASEB J (2001) 0.89
[Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon. Eur J Pharmacol (1999) 0.89
The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia. Neuroreport (2000) 0.88
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses. Immunology (1999) 0.88
EXIT procedure in a twin gestation and review of the literature. Am J Perinatol (2001) 0.88
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.88
[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist. Br J Pharmacol (2013) 0.88
Supra-agonist peptides enhance the reactivation of memory CTL responses. J Immunol (2000) 0.87
Solution structure of peptides containing two dehydro-phenylalanine residues: a CD investigation. Biopolymers (1993) 0.87
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Bone (2006) 0.87
On the stereospecific reduction of the aldolase-fructose 1,6 bisphosphate complex by NaBH4. Biochem Biophys Res Commun (1977) 0.87
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives. Br J Pharmacol (2014) 0.87
Synthesis of novel anti-inflammatory peptides derived from the amino-acid sequence of the bioactive protein SV-IV. Eur J Biochem (2001) 0.86
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci (2002) 0.86
Synthesis and pharmacological activity of dermorphin and its N-terminal sequences. Int J Pept Protein Res (1982) 0.86
Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.86
Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid. Int J Pept Protein Res (1995) 0.86
Na+ mechanism of delta-opioid receptor induced protection from anoxic K+ leakage in the cortex. Cell Mol Life Sci (2009) 0.86
Physico-chemical features of the environment affect the protein conformation and the immunoglobulin E reactivity of kiwellin (Act d 5). Clin Exp Allergy (2010) 0.86
Melanosis coli. Changes in appearance when associated with colonic neoplasia. Arch Surg (1983) 0.86
Pharmacological characterization of nociceptin receptor: an in vitro study. Can J Physiol Pharmacol (1997) 0.86
Solid state and solution structure of Boc-L-Ala-delta Phe-delta Phe-NHMe: a dehydropeptide showing propensity for 3(10)-helices of both screw senses. Biopolymers (1993) 0.85
Pycnodysostosis: review and case report. Minerva Stomatol (2014) 0.85
Structure/function relationships in the hemoglobin components from moray (Muraena helena). Eur J Biochem (1995) 0.85
A 1H NMR study of human calcitonin in solution. Biochemistry (1991) 0.85
Studies on the antinociceptive effect of [Nphe1]nociceptin(1-13)NH2 in mice. Neurosci Lett (2001) 0.84
Assignment and secondary-structure determination of monomeric bovine seminal ribonuclease employing computer-assisted evaluation of homonuclear three-dimensional 1H-NMR spectra. Eur J Biochem (1995) 0.84
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes. FEBS Lett (1998) 0.84
Post-transcriptional regulation of MHC class II expression in human T cells. Cell Immunol (1992) 0.84
Conformational sampling of bioactive conformers: a low-temperature NMR study of 15N-Leu-enkephalin. J Pept Sci (1998) 0.83
A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance. J Immunol (1999) 0.83